Drug is ' Game Changer ' ; Screen Cancer Patients for TRK Fusion Drug is ' Game Changer ' ; Screen Cancer Patients for TRK Fusion

The new drug larotrectinib is a precision medicine ' game changer. ' Cancer patients should be screened for TRK fusion to find potential responders, clinicians say.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news